Maintenance PARP Inhibitor Therapy: Is Maintaining Quality of Life Enough?
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(18)30623-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2018
Authors
Publisher
Elsevier BV